3 Reasons CNMD is Risky and 1 Stock to Buy Instead

Yahoo Finance Published Updated Economy
Sign in to save

Why it matters

CONMED's shares have experienced a 15.7% loss over the past six months, underperforming the S&P 500, and may be considered a risky investment due to softer quarterly results.

Expected market reaction

Bearish Confidence 90% How confidence is read Horizon: Short term Impact: Moderate

Market impact analysis based on bearish sentiment with 90% confidence.

Evidence trail

Evidence
Source Yahoo Finance
Claim 3 Reasons CNMD is Risky and 1 Stock to Buy Instead
AI inference Bearish · 90%
Generated 2026-02-27 18:51

AI provenance

Analysed by Llama 3.1 8B Instant (Groq) Methodology v1.0 Generated
Technical identifiers
Provider tag
groq-llama-3.1-8b-instant
Analysis version
groq-llama-3.1-8b-instant
Article id
51279

Original source

Over the past six months, CONMED’s shares (currently trading at $45.91) have posted a disappointing 15.7% loss, well below the S&P 500’s 7.2% gain. This was partly due to its softer quarterly results and might have investors contemplating their next move.

Read the full article on Yahoo Finance

Original article published by Yahoo Finance on February 27, 2026. Analysis and insights provided by AnalystMarkets AI.

Related coverage

This model on similar stories

Llama 3.1 8B Instant (Groq) · 40.5% correct across 1187 scored calls on indices See the full record